Alcon jumps premarket after confirmed outlook, Q3 EPS beat

Carl Zeiss Meditec AG

12/11/2025 07:28

** Shares in Alcon ALCC.S rise 5.8% in premarket after the Swiss-American eye care group confirmed its full-year guidance, posted Q3 EPS beat

** The company reported Q3 adjusted EPS at USD 0.79 compared with LSEG IBES estimate USD 0.76

** "We see the shares up LSD-MSD, as there were some fears in the market they could downgrade FY25 guidance," J.P. Morgan says

** "The outlook was confirmed, which is important after two profit warnings earlier this year," Vontobel says

** The stock tops Swiss blue-chip index .SSMI

** The results may be a positive read across for peer Carl Zeiss Meditec AFXG.DE, a local trader says

** The German company was up 1.3% in premarket

 (Reporting by Amir Orusov)

 ((Amir.orusov@thomsonreuters.com))